RenovoRx, Inc. ( RNXT) - Key Metrics
RNXT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.01 | -$0.08 | -$0.06 | -$0.06 |
| 2025Q1 | $0.01 | -$0.08 | -$0.11 | -$0.11 |
RNXT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -4.17 |
| 2025Q1 | ? | -3.21 |
RNXT
Price: $0.87
52 week price:
Earnings Per Share: -0.33 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 20500
Market Capitalization: 34.3 million